Department of Public Health and Primary Care, Primary Care Unit, University of Cambridge, Cambridge, UK.
Oxford Centre for Education and Research in Palliative Care, Churchill Hospital, Oxford, UK.
J Gen Intern Med. 2020 Mar;35(3):874-884. doi: 10.1007/s11606-019-05482-w. Epub 2019 Nov 12.
Advance care planning is widely advocated to improve outcomes in end-of-life care for patients suffering from heart failure. But until now, there has been no systematic evaluation of the impact of advance care planning (ACP) on clinical outcomes. Our aim was to determine the effect of ACP in heart failure through a meta-analysis of randomized controlled trials (RCTs).
We searched CINAHL, Cochrane Central Register of Controlled Trials, Database of Systematic Reviews, Embase, ERIC, Ovid MEDLINE, Science Citation Index and PsycINFO (inception to July 2018). We selected RCTs including adult patients with heart failure treated in a hospital, hospice or community setting. Three reviewers independently screened studies, extracted data, assessed the risk of bias (Cochrane risk of bias tool) and evaluated the quality of evidence (GRADE tool) and analysed interventions according to the Template for Intervention Description and Replication (TIDieR). We calculated standardized mean differences (SMD) in random effects models for pooled effects using the generic inverse variance method.
Fourteen RCTs including 2924 participants met all of the inclusion criteria. There was a moderate effect in favour of ACP for quality of life (SMD, 0.38; 95% CI [0.09 to 0.68]), patients' satisfaction with end-of-life care (SMD, 0.39; 95% CI [0.14 to 0.64]) and the quality of end-of-life communication (SMD, 0.29; 95% CI [0.17 to 0.42]) for patients suffering from heart failure. ACP seemed most effective if it was introduced at significant milestones in a patient's disease trajectory, included family members, involved follow-up appointments and considered ethnic preferences. Several sensitivity analyses confirmed the statistically significant direction of effect. Heterogeneity was mainly due to different study settings, length of follow-up periods and compositions of ACP.
ACP improved quality of life, patient satisfaction with end-of-life care and the quality of end-of-life communication for patients suffering from heart failure and could be most effective when the right timing, follow-up and involvement of important others was considered.
临终关怀的预先护理计划被广泛提倡,以改善心力衰竭患者的临终关怀结局。但到目前为止,还没有系统地评估预先护理计划(ACP)对临床结果的影响。我们的目的是通过对随机对照试验(RCT)的荟萃分析来确定 ACP 在心力衰竭中的作用。
我们在 CINAHL、Cochrane 对照试验中心注册库、系统评价数据库、Embase、ERIC、Ovid MEDLINE、科学引文索引和 PsycINFO(从开始到 2018 年 7 月)中进行了检索。我们选择了包括在医院、临终关怀或社区环境中接受治疗的成年心力衰竭患者的 RCT。三名评审员独立筛选研究、提取数据、评估偏倚风险(Cochrane 偏倚风险工具)并评估证据质量(GRADE 工具),并根据干预措施描述和复制模板(TIDieR)进行分析。我们使用通用倒数方差法在随机效应模型中计算了标准化均数差(SMD)的合并效应。
14 项 RCT 共纳入 2924 名参与者,均符合所有纳入标准。ACP 对生活质量(SMD,0.38;95%CI[0.09 至 0.68])、患者对临终关怀的满意度(SMD,0.39;95%CI[0.14 至 0.64])和临终沟通质量(SMD,0.29;95%CI[0.17 至 0.42])有中度有利影响。如果 ACP 在患者疾病轨迹的重要里程碑上引入、包括家庭成员、涉及随访预约并考虑到种族偏好,则 ACP 似乎最有效。几项敏感性分析证实了统计学上显著的效应方向。异质性主要归因于不同的研究设置、随访时间长短和 ACP 的组成。
ACP 改善了心力衰竭患者的生活质量、对临终关怀的满意度和临终沟通质量,并且在考虑正确的时间、随访和重要他人的参与时可能最有效。